跳至主要内容
临床试验/NCT01847612
NCT01847612已完成3 期

Evaluation of Indocyanine Green Fluorescent Cholangiography Versus Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy: Randomized Controlled Study

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2013年7月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
150
试验地点
1
主要终点
biliary fistula rate

研究概览

简要总结

The aim of the present study is to evaluate whether the use of indocyanine green fluorescent cholangiography is responsible in a decrease of biliary fistula's rate in patients with liver diseases requiring liver resection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • benin or malignant liver disease with resection of 2 or more segments
  • liver resection by laparotomy
  • written consent

排除标准

  • previous hepatectomy
  • emergency surgery
  • allergy to indocyanine green
  • allergy to methylene blue
  • pregnancy or breastfeeding

研究组 & 干预措施

indocyanine green fluorescent cholangiography

Experimental

use of indocyanine green fluorescent cholangiography in the patients of this arm, an indocyanine green fluorescent cholangiography is performed

干预措施: indocyanine green fluorescent cholangiography (Procedure)

methylene blue

Active Comparator

injection of methylene blue during the surgery

干预措施: methylene blue (Drug)

结局指标

主要结局

biliary fistula rate

时间窗: postoperative week 4

the biliary fistula is defined as a bilirubin in the drain three times higher than the serum bilirubin. the primary endpoint will be evaluated by a medical committee composed by investigators not involved in the patients enrollment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验